Tuesday, 23 June 2020

Sanofi eyes vaccine approval by first half of 2021

The French drugmaker Sanofi says it hopes to get regulatory approval for the coronavirus vaccine it's developing with Britain's GlaxoSmithKline by the first half of next year.


There are currently no vaccines against the virus, and while a number of companies and institutions are in the race to develop one there is no guarantee of success.


Sanofi currently has two vaccine projects. Clinical trials of the GSK-linked project are due to start in September. 


No comments:

Featured Post

Hindenburg Crashes without any cogent reason

TODAY'S ECONOMICS once again proved correct  Esteemed readers will recollect that earlier TODAY'S ECONOMICS had in its editorial (D...